bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer

By Koukourakis Michael   Giatromanolaki Alexandra   O’Byrne Keneth   Cox Jiles   Krammer Barbara   Gatter Kevin   Harris Adrian  

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 545-554

Springer Publishing Company

Access to resources Recommend Favorite

The place of pemetrexed in the management of non-small-cell lung cancer patients

By Tomasini Pascale   Greillier Laurent   Khobta Nataliya   Barlesi Fabrice  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

By Chen Fengsheng   Luo Xi   Zhang Jinbiao   Lu Yang   Luo Rongcheng  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 950-957

Humana Press, Inc

Access to resources Recommend Favorite

Serum Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Levels in Advanced Stage Non-Small Cell Lung Cancer

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 576-580

Informa Healthcare

Access to resources Recommend Favorite